ARCHIVES

Has To Plan International Meeting On Threat If DNA Biohazards

This article is from The Cancer Letter archive.

Vol. 01 No. 32 | September 13, 1974

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI In November

December 28, 2001

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

Memorial Sloan Kettering Seizes Top Cancer Hospital Prize From MD Anderson in U.S. News & World Report Ranking

July 15, 2014

Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say

July 24, 2009

NCI Cancer Prevention Fellowship Program

April 28, 2000

Surveillance Treatment Option For Low-Risk Prostate Cancer

July 30, 2010